Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
152.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.20 (0.797%)
Market Cap: £1.58b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

STATEMENT FROM JD.COM

15 Mar 2024 14:01

RNS Number : 1032H
JD.com, Inc.
15 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

FOR IMMEDIATE RELEASE

 

15 MARCH 2024

 

STATEMENT FROM JD.COM ("JD.COM")

STATEMENT OF INTENTION NOT TO MAKE AN OFFER FOR CURRYS PLC ("CURRYS")

 

 

Further to the announcement on 19 February 2024 that JD.com was in the very preliminary stages of evaluating a possible transaction that may include a cash offer for the entire issued share capital of Currys, JD.com today confirms that, following careful consideration, it does not intend to make an offer for Currys.

 

This is a statement to which Rule 2.8 of the Code applies.

 

For the purposes of Note 2 on Rule 2.8 of the Code, JD.com and any person(s) acting in concert with it reserve the right to make or participate in an offer for Currys (and/or take any other actions which would otherwise be restricted under Rule 2.8 of the Code) within the next six months following the date of this announcement:

 

(i) with the agreement of Currys' Board;

 

(ii) following the announcement of a firm intention to make an offer for Currys by or on behalf of a third party;

 

(iii) following the announcement by Currys of a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or

 

(iv) where the Takeover Panel has determined that there has been a material change of circumstances.

 

Enquiries:

 

Goldman Sachs International Tel: +4420 7774 1000

Andre Kelleners

Milan Hasecic

Chris Emmerson

 

Important notices

 

This announcement is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for or sell or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction.

The release, publication or distribution of this announcement in whole or in part in, into or from certain jurisdictions may be restricted by law and therefore persons in such jurisdictions should inform themselves about and observe such restrictions.

 

Goldman Sachs International, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the UK, is acting exclusively for JD.com and no one else in connection with the matters set out in this announcement and will not be responsible to anyone other than JD.com for providing the protections afforded to clients of Goldman Sachs International or for providing advice in connection with the matters referred to in this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDSFUFDIELSEID
Date   Source Headline
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 202511:02 amRNSBoard committee change
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 202511:20 amRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20252:11 pmRNSResult of AGM
4th Sep 20257:00 amRNSAppointment of Rune Bjerke
4th Sep 20257:00 amRNSLaunch of £50m Share Buyback Programme
4th Sep 20257:00 amRNSStrong start to year, new £50m share buyback
1st Sep 20251:36 pmRNSTotal Voting Rights
20th Aug 20259:33 amRNSDirector/PDMR Shareholding
12th Aug 20252:41 pmRNSDirector/PDMR Shareholding
1st Aug 20259:30 amRNSTotal Voting Rights
31st Jul 20252:51 pmRNSDirector/PDMR Shareholding
31st Jul 202512:28 pmRNSHolding(s) in Company
31st Jul 202510:38 amRNSAnnual Financial Report
28th Jul 20252:02 pmRNSDirector/PDMR Shareholding
23rd Jul 20254:33 pmRNSDirector/PDMR Shareholding
23rd Jul 202511:15 amRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSAppointment of Joint Corporate Broker
3rd Jul 20257:00 amRNSStrengthening performance drives profit & cashflow
1st Jul 20251:18 pmRNSDirectorate Change
1st Jul 20258:10 amRNSTotal Voting Rights
12th Jun 20253:02 pmRNSHolding(s) in Company
3rd Jun 20254:19 pmRNSHolding(s) in Company
2nd Jun 202510:56 amRNSTotal Voting Rights
21st May 20257:00 amRNSFY Trading - Performance continues to strengthen
19th May 20253:23 pmRNSHolding(s) in Company
16th May 20253:43 pmRNSHolding(s) in Company
9th May 202510:00 amRNS-RYellowstone Advisory Private Investor Evening
1st May 20258:41 amRNSTotal Voting Rights
29th Apr 20254:37 pmRNSHolding(s) in Company
4th Apr 20251:43 pmRNSHolding(s) in Company
3rd Apr 20257:00 amRNSProfits expected to be above previous guidance
1st Apr 202510:30 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.